A European Declaration on Immunotherapy

Allergy today is a public health concern of pandemic proportions, affecting more than 150 million people in Europe only. Taking into account the epidemiological trends, the European Academy of Allergy and Clinical Immunology (EAACI) predicts that in less than 15 years more than half of the European population will suffer from some type of allergy.  Allergic patients do not only suffer from a debilitating disease, with a major impact on their quality of life, career progression....

Read more
Last updated 05 August 2011